O-2113

O-2113
Identifiers
	IUPAC name (6aR,10aR)-3-(1-Ethanesulfonylamino-5-methyl-hexan-5-yl)-6a,7,10,10a-tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran;
PubChem CID	11775273;
ChemSpider	26333261;
CompTox Dashboard (EPA)	DTXSID501030081 ;
Chemical and physical data
Formula	C25H39NO4S
Molar mass	449.65 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES C13CC=C(C)CC3c2c(OC1(C)C)cc(C(C)(C)CCCCNS(=O)(=O)CC)cc2O;
	InChI InChI=1S/C25H39NO4S/c1-7-31(28,29)26-13-9-8-12-24(3,4)18-15-21(27)23-19-14-17(2)10-11-20(19)25(5,6)30-22(23)16-18/h10,15-16,19-20,26-27H,7-9,11-14H2,1-6H3/t19-,20-/m1/s1; Key:UMJJTCXPFDHKGJ-WOJBJXKFSA-N;
	(what is this?)

O-2113 is a drug that is a classical cannabinoid derivative,^[1] which acts as a potent agonist for cannabinoid receptors, producing sedation, hypothermia and analgesia in animal studies.^[2]

References

^ Wiley JL, Breivogel CS, Mahadevan A, Pertwee RG, Cascio MG, Bolognini D, et al. (January 2011). "Structural and pharmacological analysis of O-2050, a putative neutral cannabinoid CB(1) receptor antagonist". European Journal of Pharmacology. 651 (1–3): 96–105. doi:10.1016/j.ejphar.2010.10.085. PMC 3034309. PMID 21114999.
^ US 7279500, Martin BR, Razdan RJ, Pertwee RG, "Sulfonamide Cannabinoid Agonists and Antagonists", published 5 May 2005

This cannabinoid related article is a stub. You can help Wikipedia by expanding it.

Identifiers

IUPAC name (6aR,10aR)-3-(1-Ethanesulfonylamino-5-methyl-hexan-5-yl)-6a,7,10,10a-tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran
PubChem CID	11775273
ChemSpider	26333261
CompTox Dashboard (EPA)	DTXSID501030081
Chemical and physical data
Formula	C₂₅H₃₉NO₄S
Molar mass	449.65 g·mol⁻¹
3D model (JSmol)	Interactive image
SMILES C13CC=C(C)CC3c2c(OC1(C)C)cc(C(C)(C)CCCCNS(=O)(=O)CC)cc2O
InChI InChI=1S/C25H39NO4S/c1-7-31(28,29)26-13-9-8-12-24(3,4)18-15-21(27)23-19-14-17(2)10-11-20(19)25(5,6)30-22(23)16-18/h10,15-16,19-20,26-27H,7-9,11-14H2,1-6H3/t19-,20-/m1/s1 Key:UMJJTCXPFDHKGJ-WOJBJXKFSA-N
^NY (what is this?)